The US Food and Drug Administration (FDA) has approved sugammadex injection (Bridion, Merck) for the reversal of moderate or deep neuromuscular blockade induced by rocuronium or vecuronium during surgery, according to an agency news release. The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee recommended approval of the drug back in November. Sugammadex binds to rocuronium and […]
Read MoreASA Monitor 12 2015, Vol.79, 36-37. Case 2015-12: A Different Point of View A 34-year-old man, newly paraplegic from a gunshot wound, presented for thoracic spine instrumentation. While his ventilatory reserve was poor, his airway was patent in his baseline awake state, and minute ventilation was adequate. After induction with propofol and rocuronium, bag mask ventilation […]
Read MoreAuthor: Uday Jain MD PhD ASA Monitor 12 2015, Vol.79, 28-30. Anesthesia and critical care during disasters and in austere environments requires improvisation.1 –4 Partially trained personnel utilize some techniques, often adequately, yet occasionally dangerously. Triage is essential to prioritize care. Preoperative, recovery and postoperative care is often inadequate. In disasters, casualties exceed resources. Critical resources may be […]
Read MoreAuthors: Marc P. Steurer, MD, DESA et al ASA Monitor 12 2015, Vol.79, 18-20. There are interesting similarities and differences in clinical anesthesia practice and organization between the U.S. and Europe.A detailed analysis stratified for all European countries and the different regions of the U.S. is beyond the scope of this newsletter. However, since both authors have […]
Read MoreAuthors: Jerrold H Levy MD FAHA, FCCM et al ASA Monitor 12 2015, Vol.79, 14-16. Over the years, we all have had the privilege of working and collaborating with many physician anesthesiologists in the United States, Europe and various other countries. In Europe, anesthesiology is a physician-focused practice and nurses function in different supporting roles; in some countries, […]
Read More